SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
33 hedge funds and large institutions have $47.2M invested in Sinovac Biotech, Ltd in 2013 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
–
Reduced
–
Closed
–
Calls
$386K
Puts
$130K
Net Calls
+$256K
Net Calls Change
+$256K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIG
26
American International Group
New York
| $14.1K | +$14.1K | +3,600 | New |
|
|
U
27
UBS
Zurich,
Switzerland
| $10K | +$10K | +2,664 | New |
|
28
Barclays
London,
United Kingdom
| $4K | +$4K | +980 | New |
|
|
MFS
29
MSI Financial Services
Springfield,
Massachusetts
| $4K | +$4K | +1,000 | New |
|
30
Wells Fargo
San Francisco,
California
| $3K | +$3K | +750 | New |
|
31
Ameriprise
Minneapolis,
Minnesota
| $1K | +$1K | +200 | New |
|
|
AA
32
Apriem Advisors
Irvine,
California
| $1K | +$1K | +300 | New |
|